Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Jean Hu‐Primmer
Observed names:
Jean Hu-Primmer,
Jean Hu-primmer
Institution:
Moderna Therapeutics (United States)
Observed institutions:
Centers for Disease Control and Prevention,
National Institutes of Health,
United States Food and Drug Administration,
National Center for Immunization and Respiratory Diseases,
Moderna Therapeutics (United States),
National Center for Infectious Diseases
show all 6
OpenAlex ID:
A5035049516
Detection of Antibody to Avian Influenza A (H5N1) Virus in Human Serum by Using a Combination of Serologic Assays
1999
·
Thomas Rowe
, Robert A. Abernathy
, et al.
·
Journal of Clinical Microbiology
·
851
PDF
Safety and immunogenicity of a recombinant hemagglutinin vaccine for H5 influenza in humans
2001
·
John J. Treanor
, Bethanie E. Wilkinson
, et al.
·
Vaccine
·
344
Risk of Influenza A (H5N1) Infection among Poultry Workers, Hong Kong, 1997–1998
2002
·
Carolyn Buxton Bridges
, Wilina Lim
, et al.
·
The Journal of Infectious Diseases
·
319
Antibody Response in Individuals Infected with Avian Influenza A (H5N1) Viruses and Detection of Anti‐H5 Antibody among Household and Social Contacts
1999
·
Jacqueline M. Katz
, Wilina Lim
, et al.
·
The Journal of Infectious Diseases
·
270
Risk of Influenza A (H5N1) Infection among Health Care Workers Exposed to Patients with Influenza A (H5N1), Hong Kong
2000
·
Carolyn Buxton Bridges
, Jacqueline M. Katz
, et al.
·
The Journal of Infectious Diseases
·
259
Lack of Evidence for Human-to-Human Transmission of Avian Influenza A (H9N2) Viruses in Hong Kong, China 19991
2002
·
Timothy M. Uyeki
, Yu-Hoi Chong
, et al.
·
Emerging infectious diseases
·
109
Seroprevalence of Antibodies to Avian Influenza A (H5) and A (H9) Viruses among Market Poultry Workers, Hanoi, Vietnam, 2001
2012
·
Timothy M. Uyeki
, Doan C. Nguyen
, et al.
·
PLoS ONE
·
76
PDF
Immunity to Influenza A H9N2 Viruses Induced by Infection and Vaccination
2001
·
Xiuhua Lu
, Mary Renshaw
, et al.
·
Journal of Virology
·
62
Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
2016
·
Timothy M. Uyeki
, Karl J. Erlandson
, et al.
·
Emerging infectious diseases
·
21
PDF
Meeting the challenges of medical countermeasure development
2012
·
Carmen Maher
, Jean Hu‐Primmer
, et al.
·
Microbial Biotechnology
·
11
PDF
Evaluating Promising Investigational Medical Countermeasures: Recommendations in the Absence of Guidelines
2019
·
Nahid Bhadelia
, Lauren Sauer
, et al.
·
Health Security
·
7
Monitoring and Assessment of Medical Countermeasures as Part of a Public Health Emergency Response
2018
·
Gregory T. Measer
, Carmen T. Maher
, et al.
·
American Journal of Public Health
·
5
220. Safety and Immunogenicity of mRNA-1018, a candidate vaccine for the prevention of H5N1 pandemic influenza, in healthy adults ≥18 years of age in a dose-ranging Phase 1/2 clinical study
2026
·
Natalia V Voge
, Catherine A Cosgrove
, et al.
·
Open Forum Infectious Diseases
·
2
Show more works
View as search
Works count:
14
Citation count:
2,336
H-index:
10
I10-index:
10
Year
Topic
Type